71 related articles for article (PubMed ID: 6192962)
1. Evaluation of hetastarch.
Nakasato SK
Clin Pharm; 1982; 1(6):509-14. PubMed ID: 6192962
[TBL] [Abstract][Full Text] [Related]
2. Hetastarch: an alternative colloid in burn shock management.
Waters LM; Christensen MA; Sato RM
J Burn Care Rehabil; 1989; 10(1):11-6. PubMed ID: 2466034
[TBL] [Abstract][Full Text] [Related]
3. Hetastarch (Hespan)--a new plasma expander.
Med Lett Drugs Ther; 1981 Feb; 23(4):16. PubMed ID: 6162082
[No Abstract] [Full Text] [Related]
4. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
5. [Hydroxyethyl starch--a new interesting colloidal plasma volume expander. Anaphylactoid reactions (author's transl)].
Seidemann J
Zentralbl Chir; 1979; 104(22):1457-64. PubMed ID: 95073
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of colloidal volume replacement solution 6% HES 40/0.5].
Halmágyi M
Anaesthesist; 1984 Feb; 33(2):73-81. PubMed ID: 6201084
[TBL] [Abstract][Full Text] [Related]
7. State of investigations on hydroxyethylstarch.
Lutz H; Hartung HJ
Acta Anaesthesiol Belg; 1984; 35 Suppl():21-6. PubMed ID: 6083692
[No Abstract] [Full Text] [Related]
8. [Clinical experience and blood volume measurement following intravenous administration of hydroxyethylstarch 450/0.7 (author's transl)].
Bergmann H; Necek S
Wien Med Wochenschr; 1980 Jun; 130(11):367-9. PubMed ID: 6160681
[TBL] [Abstract][Full Text] [Related]
9. Does OxyVita, a new-generation hemoglobin-based oxygen carrier, or oxyglobin acutely interfere with coagulation compared with normal saline or 6% hetastarch? An ex vivo thromboelastography study.
Jahr JS; Weeks DL; Desai P; Lim JC; Butch AW; Gunther R; Driessen B
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):34-9. PubMed ID: 18249328
[TBL] [Abstract][Full Text] [Related]
10. Effect of an equal volume replacement with 500 mL 6% hydroxyethyl starch on the blood and plasma volume of healthy volunteers.
Mortelmans Y; Merckx E; van Nerom C; Verbruggen A; van Aken H; de Roo M; Mortelmans L
Eur J Anaesthesiol; 1995 May; 12(3):259-64. PubMed ID: 7543845
[TBL] [Abstract][Full Text] [Related]
11. Does Hextend impair coagulation compared to 6% hetastarch? An ex vivo thromboelastography study.
Weeks DL; Jahr JS; Lim JC; Butch AW; Driessen B
Am J Ther; 2008; 15(3):225-30. PubMed ID: 18496260
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in children: preliminary results of a European Prospective Multicenter Observational Postauthorization Safety Study (PASS).
Sümpelmann R; Kretz FJ; Gäbler R; Luntzer R; Baroncini S; Osterkorn D; Haeger MC; Osthaus WA
Paediatr Anaesth; 2008 Oct; 18(10):929-33. PubMed ID: 18647272
[TBL] [Abstract][Full Text] [Related]
13. [Hemodynamic changes following rapid infusion of a plasma substitute, hydroxyethyl starch. Evaluation of its effect on the circulating blood volume and application to left ventricular function test].
Yamada T; Sakamoto T
Masui; 1975 Sep; 24(9):891-8. PubMed ID: 53297
[No Abstract] [Full Text] [Related]
14. Isovolemic hemodilution alters the ratio of whole-body to large-vessel hematocrit (F-cell ratio). A prospective, randomized study comparing the volume effects of hydroxyethyl starch 200,000/0.62 and albumin.
Haller M; Brechtelsbauer H; Akbulut C; Fett W; Briegel J; Finsterer U
Infusionsther Transfusionsmed; 1995 Apr; 22(2):74-80. PubMed ID: 7540445
[TBL] [Abstract][Full Text] [Related]
15. [A new hydroxyethyl starch for volume replacement: Elohes 6%].
Medel J; Baron JF
Rev Esp Anestesiol Reanim; 1998 Nov; 45(9):389-96. PubMed ID: 9847657
[TBL] [Abstract][Full Text] [Related]
16. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial.
Godet G; Lehot JJ; Janvier G; Steib A; De Castro V; Coriat P
Eur J Anaesthesiol; 2008 Dec; 25(12):986-94. PubMed ID: 18492315
[TBL] [Abstract][Full Text] [Related]
17. [Second effect on volume after a one-time infusion of hydroxyethyl starch].
Köhler H; Kirch W; Pitz H
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1756-8. PubMed ID: 77106
[No Abstract] [Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
19. Hetastarch: an overview of the colloid and its metabolism.
Hulse JD; Yacobi A
Drug Intell Clin Pharm; 1983 May; 17(5):334-41. PubMed ID: 6190620
[TBL] [Abstract][Full Text] [Related]
20. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
